As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
The chief researcher of China's first general-use COVID vaccine was ousted last week from the country's highest organ of power. Yang Xiaoming, 62, was booted on April 23 from the National People's ...
Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. Pharmaceutical giant AstraZeneca has accepted for the first time ...
Jamie Scott was left with a permanent brain injury after having a haemorrhage the day after the Covid vaccine Credit: Andrew Fox AstraZeneca has admitted for the first time in court documents that ...
A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known of the risk of rare but serious side ...
A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known of the risk of rare but serious side ...
Do you have questions surrounding COVID-19, the vaccine and impacts on our communities? ABC13 is committed to finding answers and connecting you with resources. Man deliberately gets 217 Covid ...
Mar. 8, 2024 — COVID-19 ... the century-old vaccine reduced tumors and extended survival for mice with liver ... Feb. 20, 2024 — A study has shown that shortly after an increase in ...
In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited ...
Moderna's COVID-19 Vaccine Safe and Effective for Young Children, Study Finds Nov. 4, 2022 — Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical ...